Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
Alzheimer’s disease (AD) is the most common cause of dementia. The two major hallmarks of this disease are extracellular amyloid plaques and intracellular neurofibrillary tangles in the brain, accompanied by loss of neurons and synapses. The plaques and tangles mainly consist of amyloid-β (Aβ) and t...
Saved in:
| Main Authors: | Futao Zhou, Yushi Zhao, Yangyan Sun, Wanjiao Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-10-01
|
| Series: | Journal of Integrative Neuroscience |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/JIN/23/11/10.31083/j.jin2311197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01) -
Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
by: Eliasz Engelhardt, et al.
Published: (2024-12-01) -
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
by: D. Luke Fischer, et al.
Published: (2025-01-01) -
Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01) -
Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer’s diseases
by: Sookhee Bang, et al.
Published: (2024-12-01)